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Abstract
Pancreatic b cells express several P2 receptors including P2Y1 and the modulation of insulin secretion by extracellular
nucleotides has suggested that these receptors may contribute to the regulation of glucose homeostasis. To determine
whether the P2Y1 receptor is involved in this process, we performed studies in P2Y1j/j mice. In baseline conditions,
P2Y1j/j mice exhibited a 15% increase in glycemia and a 40% increase in insulinemia, associated with a 10% increase
in body weight, pointing to a role of the P2Y1 receptor in the control of glucose metabolism. Dynamic experiments
further showed that P2Y1j/j mice exhibited a tendency to glucose intolerance. These features were associated with a
decrease in the plasma levels of free fatty acid and triglycerides. When fed a lipids and sucrose enriched diet for 15
weeks, the two genotypes no longer displayed any significant differences. To determine whether the P2Y1 receptor was
directly involved in the control of insulin secretion, experiments were carried out in isolated Langerhans islets. In the
presence of high concentrations of glucose, insulin secretion was significantly greater in islets from P2Y1j/j mice.
Altogether, these results show that the P2Y1 receptor plays a physiological role in the maintenance of glucose
homeostasis at least in part by regulating insulin secretion.
Introduction
Extracellular nucleotides regulate biological processes as
diverse as smooth muscle contraction, neurotransmission,
the immune response, inflammation, platelet aggregation,
pain or the modulation of cardiac functions by acting on
specific receptors [1]. These so-called P2 receptors are
divided into two families: The metabotropic P2Y and
ionotropic P2X receptors. P2Y receptors are 7-transmem-
brane domain, G protein-coupled polypeptides, of which
eight subtypes have been cloned and characterized to date,
differing in their sequence, pharmacological properties and
intracellular signaling. The first P2Y receptor to be cloned
[2], thus named P2Y1, is an ADP receptor expressed in a
wide range of tissues which activates PLCb through Gq
coupling [3, 4]. Although the precise physiological func-
tion of this receptor in most tissues is not yet known, its
role in hemostasis and thrombosis is now firmly estab-
lished [5]. The P2Y1 receptor is expressed in platelets [3]
and together with the P2Y12 receptor plays an important
role in the platelet aggregation induced by ADP or other
aggregating agents [6Y9]. Thus, P2Y1-deficient mice and
wild-type (wt) mice treated with a P2Y1 antagonist are
resistant to thrombosis in several experimental models
[9Y13].
A growing body of evidence suggests that P2 receptors
may be involved in the regulation of glucose homeostasis.
Pancreatic b cells express a wide range of P2 receptors
including P2Y subtypes [14], while stable analogues of
ATP and ADP have been shown to increase insulin
secretion and decrease glycemia in vivo [15]. In addition,
potent P2Y1 agonists have been described as insulin
secretagogues in isolated rat pancreas [16], suggesting the
functional participation of a P2Y1-like receptor in this
mechanism. A role of P2Y receptors in glucose transport
has also been proposed in rat cardiomyocytes [17] and
human skin fibroblasts [18].
To determine whether the P2Y1 receptor subtype is
involved in the regulation of glucose homeostasis, we
performed studies in P2Y1j/j mice. P2Y1 deficiency was
found to result in increases in glycemia and insulinemia in
the nonfasting state, associated with increased body weight
and decreased plasma levels of free fatty acids and
triglycerides. In vitro experiments in isolated pancreatic
Correspondence to: Dr Christian Gachet, Institut National de la Sante ´ et
de la Recherche Me ´dicale U.311, Etablissement Franc ¸ais du Sang-Alsace,
10 rue Spielmann 67065, Strasbourg Cedex, France. Tel: +33-388-
212525; Fax: +33-388-212521; E-mail: christian.gachet@efs-alsace.fr
Purinergic Signalling (2005) 1: 145–151 # Springer 2005islets showed an increased insulin secretion in P2Y1-
deficient mice, suggesting a role of the P2Y1 receptor in
the maintenance of glucose homeostasis and in the
regulation of insulin secretion.
Materials and methods
Animals
Wild-type and P2Y1-deficient male and female mice were
raised as described previously [9] and had a C57BL/6
background at the F7 generation. Animals used in the
experiments were aged-matched (10Y12 weeks old except
otherwise stated), housed at 22 -C under a 12-h light/dark
cycle and had free access to food and water. The mice were
normally fed a standard laboratory chow containing about
3% fat (Safe, Epinay/Orge, France). Body weight was
monitored by weighing the mice from weaning (21 days) to
12 months and food intake by weighing the grid metal food
container every 2Y3 days for 2 weeks and dividing the
result by the number of mice per cage (three mice) and the
number of days. The high fat/high sucrose diet (HF/HS),
which was administered for 15 weeks, contained 24% fat
(hydrogenated coconut oil) and was enriched in sucrose
(30%) (Research Diets, New Brunswick, USA).
Lipid measurements
After an 8-h fast, mice were anesthetized with methoxy-
flurane and blood was drawn from the abdominal aorta into
heparin lithium (20 U/ml) as anticoagulant. Plasma
triglycerides, total cholesterol and HDL-cholesterol were
determined using an Olympus AU400 analyzer (Olympus
SA, Rungis, France) with kits and controls supplied by
Olympus. Free fatty acids were measured on the AU400
analyzer using a kit from Wako (Richmond, USA).
Plasma glucose
Glucose tolerance was determined following a 24-h fast by
i.p. administration of glucose (3 g/kg) and measurement of
plasma glucose at 15, 30, 60 and 120 min. Insulin
sensitivity was determined in mice fasted for 4 h by i.p.
injection of insulin (Humulin, 0.75 mg/kg; Eli Lilly,
France) and measurement of plasma glucose at 15, 30, 60
and 90 min. Blood samples were collected from the tail tip
of conscious mice and glucose concentrations were
measured using glucose analyzer strips (Accu-Chek active,
Roche, Mannheim, Germany).
Insulin measurements
Mice were fasted for 4 h and injected with glucose (3 g/kg).
Blood was taken from the orbital plexus of conscious mice
at 0, 30 and 60 min and insulin was measured with a
monoclonal insulin RIA (Linco Research, St Louis, MO).
For the determination of insulin content in the whole
pancreas, each mouse pancreas was homogenized in 4 ml
of ice-cold acidYethanol solution (0.15 N HCl:75%
ethanol) [19], and insulin was extracted at 4 -C overnight.
Insulin concentrations were assayed in 1,000-fold or
10,000-fold diluted samples.
Insulin secretion in isolated pancreatic islets
Langerhans islets from wild-type and P2Y1-deficient
female mice were isolated by collagenase digestion of the
pancreas according to a technique derived from that of
Lacy and Kostianowsky [20]. The islets were stabilized for
45 min at 37 -C in a KrebsYbicarbonate buffer containing
(mmol/l) NaCl 108, NaHCO3 18, KCl 4.7, CaCl2 2.5,
MgSO4 1.2 and KH2PO4 1.2 (pH 7.4), bubbled with a
mixture of O2:CO2 (95%:5%) and supplemented with
glucose (5 mmol/l) and bovine serum albumin (Fraction
V, 1 mg/ml). Thereafter, batches of three islets from wild-
type and P2Y1j/j mice were incubated for 60 min in 1 ml
of KrebsYbicarbonate buffer containing different concen-
trations of glucose (3, 7, 11 and 20 mmol/l). At the end of
the incubation period, a sample of the medium was taken
for immunoassay of insulin.
Histological examination of mouse pancreas and
determination of the percentage of fat mass
For histological examination, mouse pancreas were fixed in
10% buffered neutral formalin and embedded in paraffin.
For each pancreas, one slide containing three histological
sections was stained with hematoxylin/eosin. The determi-
nation of body fat percentage was performed at the Mouse
Clinical Institute (Illkirch, France), using a Piximus ap-
paratus (GE Medical System, Madison, Wisconsin, USA).
Statistical analyses
Values are reported as the mean T SEM and nonparametric
MannYWhitney tests were performed to compare two
groups of independent values, and the areas under the
GTT curves were calculated to compare the difference
between wt and P2Y1j/j mice in the glucose tolerance
test. A Wilcoxon matched pairs test was used to compare
the difference in body weight between wild-type and
P2Y1j/j mice.
Results
Increased glycemia and body weight despite normal food
consumption in P2Y1j/j mice
The effect of P2Y1 deficiency on glycemia was assessed
according to the nutritional status of the animals. On a
normal chow diet, the plasma glucose level in nonfasted
animals was significantly increased in P2Y1j/j male
mice as compared to wild-type (wt) male mice (9.79 T 0.33
and 7.95 T 0.30 mmol/l, respectively, P G 0.01). A similar
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although it did not reach statistical significance (8.98 T
0.23 and 8.15 T 0.38 mmol/l, respectively) (Figures 1a and
b). After a 6-h fast, the difference in glucose level between
the two genotypes was still significant in P2Y1j/j and wt
males (9.5 T 0.59 and 7.85 T 0.29 mmol/l, respectively,
P G 0.05), but not in P2Y1j/j and wt females (9.10 T 0.20
and 7.53 T 0.48 mmol/l, respectively) (Figures 1a and b).
However, after an overnight fast, no significant difference
was observed between P2Y1j/j and wt males (4.89 T
0.19 and 4.56 T 0.15 mmol/l, respectively) or females (4.92
T 0.25 and 4.60 T 0.20 mmol/l, respectively) (not shown).
The increase in glycemia in fed and 6-h-fasted mice was not
due to an increase in food consumption, which was similar
in wt and P2Y1j/j mice (Figure 2a). It was nevertheless
associated with a significant 10% increase in body weight
for P2Y1j/j as compared to wt male mice, which was
maintained for up to 10 months (P G 0.0001) (Figure 2b),
whereas no difference was observed between wt and
P2Y1j/j females (data not shown). Body fat percentages
showed a slight increase for the male P2Y1j/j mice,
although the difference did not reach statistical signifi-
cance (10.7 T 0.6 and 11.5 T 0.5% of fat tissue for wt and
P2Y1j/j, respectively, n = 4). Similarly, the difference in
plasma leptin levels, which reflect the amount of fat tissue,
was not statistically different between the two genotypes
(Table 1).
Biochemical parameters
A metabolic study revealed that plasma free fatty acids and
triglycerides were about 20% lower (P G 0.05 and 0.01,
respectively) in P2Y1j/j as compared to wt fasted male
mice (Table 1), whereas no significant differences were
observed in the nonfasted state (data not shown). No
significant difference was observed in fasted or nonfasted
female mice, whatever the parameter (Table 1). In view of
these results, further dynamic experiments were performed
in male mice only.
Glucose tolerance and insulin sensitivity
An i.p. glucose challenge (3 g/kg) was administered to
determine the dynamic response of P2Y1j/j mice to
increased glucose concentrations. A slight glucose intoler-
ance was observed in P2Y1-deficient mice as compared to
wt mice (P G 0.05) (Figure 3a). The insulin sensitivity of
mice fasted for 4 h was investigated by i.p. injection of
insulin (0.75 U/kg) and measurement of plasma glucose
concentrations over time. Although P2Y1j/j mice fasted
for 4 h still exhibited increased glycemia, the glucose
lowering effect of insulin was similar in these animals as
compared to wt mice (Figure 3b). Insulin measurements
revealed a 40% increased level in P2Y1j/j mice in the
nonfasting state (4 h food withdrawal). However, after
injection of glucose (3 g/kg), no significant difference in
insulin levels was observed between the two genotypes at
30 and 60 min (Table 2).
Glucose tolerance, insulin sensitivity and plasma lipids in
mice fed an HF/HS diet
To determine whether these slight differences could be
exacerbated by diet, wt and P2Y1-deficient mice were fed a
high fat/high sucrose diet for 15 weeks. This diet resulted
Figure 1. Plasma glucose concentrations. Plasma glucose was measured
in conscious mice in the fed state or fasted for 6 h. (a) Male mice (n = 9),
(b) female mice (n =1 0 Y12). Results are the mean T SEM; ns,
nonsignificant; *P G 0.05; **P G 0.01.
Figure 2. Food consumption (a) and growth (b) curves of wt and
P2Y1j/j male mice. Data are the mean T SEM (n = 9) and the difference
in body weight was significant (P G 0.0001, Wilcoxon matched pairs test).
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0.01). However, no more difference in body weight was
observed between wt and P2Y1j/j mice fed the enriched
diet (Figure 4a). The diet elicited glucose intolerance in
both genotypes relative to the respective mice fed a
normal chow diet, though after an overnight fast, gly-
cemia remained identical whatever the genotype or diet
(Figures 3a and 4b). In addition, no more significant
difference in glucose tolerance or insulin sensitivity was
observed between wt and P2Y1j/j mice fed the HF/HS
diet (Figures 4b and c). After the 4-h fast, glycemia was
nevertheless still higher in P2Y1j/j mice fed the
enriched diet (Figure 4c). Concerning plasma lipids,
neither triglycerides nor free fatty acids displayed any
significant difference after the HF/HS diet (Table 1).
Pancreas morphology and insulin content, and insulin
secretion in isolated pancreatic islets
Histological analysis of mouse pancreas revealed no
difference between wt and P2Y1j/j mice (n =4 )
regarding islets morphology. Pancreas weight was similar
between the two genotypes (307.6 T 30.1 and 296.2 T 27.9
mg of tissue for the wt and P2Y1j/j mouse pancreas,
respectively, n = 5). The insulin content of P2Y1j/j mice
pancreas was not significantly different from that of wt
mice (90.68 T 7.75 and 142.3 T 23.32 mg insulin/g
tissue for the wt and P2Y1j/j pancreas, respectively,
n =5 ,P 9 0.05). To assess the potential physiological role
of the P2Y1 receptor in the function of pancreatic b cells,
we compared the insulin responses of pancreatic islets from
wt and P2Y1-deficient mice to increasing concentrations of
glucose in vitro. The insulin response of wt islets increased
with the level of glucose in the medium, from 0.63 T 0.07
ng/islet per hour at 3 mmol/l glucose to 1.41 T 0.14 ng/islet
per hour at 20 mmol/l glucose (Figure 5). In the presence
of a non-stimulating glucose concentration (3 mmol/l), the
level of insulin secretion was similar in islets from
P2Y1j/j (0.58 T 0.09 ng/islet per hour) and wt mice.
However, in islets from P2Y1j/j mice, the insulin
response to a stimulatory glucose concentration (20
mmol/l) was significantly greater (2.0 T 0.2 ng/islet per
hour, P G 0.02) than the secretion in wt islets (Figure 5).
Figure 3. Glucose tolerance and insulin sensitivity of wt and P2Y1j/j
mice. Plasma glucose levels were measured over time following
intraperitoneal injection of glucose (3 g/kg) (a, n =9 ;P G 0.05) or insulin
(0.75 U/kg) (b, n = 7). Values are the means T SEM. P indicates
significant difference between the two area under the curve.
Table 1. Plasma levels of leptin and cholesterol, HDL-cholesterol, triglycerides and fatty acids in wt and P2Y1j/j mice fasted for 8 h (mean T
SEM, n = 6).
Male Female
wt P2Y1j/j wt P2Y1j/j
Cholesterol (mmol/l) 1.84 T 0.18 1.86 T 0.11 1.62 T 0.15 1.54 T 0.13
HDL-C (mmol/l) 1.27 T 0.18 1.32 T 0.06 1.03 T 0.11 1.04 T 0.09
Triglycerides (mmol/l) 0.81 T 0.03 0.66 T 0.03
b 0.61 T 0.11 0.62 T 0.07
Fatty acids (mmol/l) 0.74 T 0.04 0.60 T 0.04
a 0.78 T 0.06 0.68 T 0.04
Leptin (mmol/l) 0.28 T 0.07 0.56 T 0.23 0.43 T 0.23 0.83 T 0.37
Triglycerides (mmol/l)
c 0.76 T 0.06 0.72 T 0.04 nd nd
Fatty acids (mmol/l)
c 0.67 T 0.06 0.63 T 0.03 nd nd
C, cholesterol; nd, not determined.
aP G 0.05.
bP G 0.01.
cMeasured after 15 weeks on a high fat/high sucrose diet.
Table 2. Plasma insulin levels following glucose injection (3 g/kg)
(n = 20).
Time (min) 0 30 60
wt (ng/ml) 0.248 T 0.022 0.318 T 0.036 0.190 T 0.022
P2Y1j/j (ng/ml) 0.346 T 0.024
a 0.278 T 0.035 0.168 T 0.013
aP G 0.01.
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In this study, we investigated the effects of P2Y1
deficiency on the regulation of glucose homeostasis in
mice. The most striking observations were increased
glycemia and insulinemia in non-fasted P2Y1-deficient
animals as compared to wt mice, although a difference
could no longer be detected after an overnight fast. These
metabolic features were associated in males with an
increase in body weight for P2Y1-deficient as compared
to wt mice, whereas no difference in food consumption was
observed between the two genotypes. The occurrence of a
significant rise in glycemia together with a 40% increase in
insulinemia in P2Y1-deficient mice would favor the
presence of a state of insulin resistance induced by deletion
of the P2Y1 gene, in the absence of any increase in food
intake.
It is worthy of note that the increase in insulin level was
evident under basal conditions (4 h post-prandial), but not
after an overnight fast or even under dynamic stimulated
conditions. In the glucose tolerance test, a slight decrease
in tolerance could be observed in the basal state although it
should be noted that the test was performed with a
relatively high dose of glucose (3 g/kg) which may have
emphasized a mild phenotype. In addition, no significant
difference in insulin sensitivity was observed. These
findings may be explained by a mild defect of glucose
transport as suggested by the work of Solini and coworkers
[18]; this defect may be functionally relevant only in the
post-prandial period. Regarding the increased insulinemia,
our in vitro data in isolated islets strongly suggest that
pancreatic b-cell function is improved in P2Y1-deficient
mice, particularly in the presence of high glucose concen-
trations, pointing to a putative inhibitory effect of the P2Y1
receptor on insulin secretion. Although it is difficult to
directly relate the in vitro data to the in vivo observations,
it should be noted that insulinemia of the P2Y1j/j mice
did not increase in vivo during a glucose challenge. One
explanation for these data is that these results may be
partly related to an abnormality in hypothalamic functions,
where the P2Y1 receptor was shown to be expressed [21,
22]. The function of islet b cells is indeed controlled by a
glucose sensor acting in synergy with signals that integrate
messages originating from other tissues, particularly the
hypothalamus [23].
The role of extracellular nucleotides in the modulation
of pancreatic insulin secretion is well known [24Y26]. It
has previously been demonstrated that adenine nucleotides
amplify insulin secretion by acting on P2 receptors of
pancreatic b cells. These receptors were found to belong to
the P2Y family, with ADPbS, ATPaS and 2MeSATP being
potent agonists in pancreatic islets isolated from rat, dog or
man [15, 27Y29]. The insulin response triggered by
activation of P2Y receptors is also known to depend on
the stimulating glucose concentration [29, 30]. Although
the subtype of receptor involved and the stimulus-secretion
coupling of b-cell P2 receptors have not yet been
unequivocally established, potent P2Y1 agonists have been
shown to be strong insulin secretagogues in rat pancreas
[16]. All these data disagree with our observation that
absence of the P2Y1 receptor contributes to increase insulin
secretion instead of decreasing it. However, the effects of
nucleotides on pancreatic cells appear to differ in the
mouse from those observed in other species such as dog,
rat or man. In mice, unlike in other species, the
Figure 5. InsulinsecretionofpancreaticisletsfromwtandP2Y1-deficient
mice in the presence of different concentrations of glucose. Results are the
mean T SEM for 26Y35 independent determinations. *P G 0.02.
Figure 4. Growth curve, glucose tolerance and insulin sensitivity of wt
and P2Y1j/j mice fed an HF/HS diet for 15 weeks. (a) The difference in
body weight was again significant when comparing wt vs P2Y1j/j mice
fed the normal chow diet (n =9 ,P G 0.01), or wt mice fed the normal
chow diet vs wt mice fed the HF/HS enriched diet (n =9 ,P G 0.01), but
not when comparing wt vs P2Y1j/j fed the enriched diet. (b, c) Plasma
glucose levels were determined after intraperitoneal administration of
glucose (3 g/kg) (b) or insulin (0.75 U/kg) (c). Results are the mean T
SEM (n = 9).
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to inhibit insulin release from islet cells [31]. Similar
observations were reported more recently [32], and the
authors showed that nucleotides had an inhibitory action on
insulin secretion through direct interference with the
secretory machinery by activation of the protein phospha-
tase calcineurin. These results are in accordance with our
findings in P2Y1j/j mice, suggesting an autocrine
inhibitory role of this receptor in mouse pancreas in the
fed state or under glucose stimulated conditions.
P2Y receptor stimulation was recently shown to partic-
ipate in glucose uptake in human fibroblasts by mediating
glucose transporter (GLUT1) translocation and activation
[18]. In fibroblasts from type 2 diabetic patients, this P2Y-
mediated glucose transport was defective due to constitu-
tive P2Y desensitization in these cells, while co-incubation
with the nucleotide degrading enzyme apyrase restored
ATP-stimulated glucose uptake. Such a phenomenon could
contribute to maintain hyperglycemia in these patients
[18]. Although the P2Y subtype involved was not clearly
identified, it would be interesting to determine whether the
P2Y1 receptor might participate in glucose transport,
which could also contribute to the phenotype observed in
P2Y1j/j mice. Desensitization of the P2Y1 receptor is
also observed in mice defective for the ectonucleotidase
NTPDase1/CD39. These mice were recently reported to
exhibit glucose intolerance, insulin resistance and a
decrease in 2-deoxyglucose uptake in cultured hepatocytes,
which adds evidence for an important role of extracellular
nucleotides in glucose homeostasis, probably at least in
part through the P2Y1 receptor [33].
Another metabolic feature found in P2Y1-deficient mice
was the decrease in plasma free fatty acids (FFA) and
triglycerides. Since the demonstration by [34] of the
existence of the glucoseYfatty acid cycle and more recently
the elucidation of its mechanism [35], the inhibition of
glucose metabolism by FFA has been well documented.
FFA should not be involved in the insulin resistance of
P2Y1j/j mice. On the contrary, the low levels of FFA
and triglycerides are consistent with no real insulin
resistance as these are normally elevated in insulin-
resistant states. Concerning the mechanism of the decrease
in plasma FFA, a direct effect of P2Y1 receptor depletion
in adipose tissue or in the liver cannot be excluded but
would appear to be unlikely. Thus, if A1 adenosine
receptors have been shown to be expressed in adipocytes
and to play an important physiological role in lipolysis
control and insulin sensitivity [36], no information is
available on the existence of P2Y1 receptors on adipocytes.
I nt h es a m ew a y ,P 2 Y 1 receptors are expressed in
hepatocytes where they have recently been shown to
stimulate glycogenolysis through activation of glycogen
phosphorylase [37] but there is currently no evidence for
the role of P2Y1 receptors in fat metabolism. The decrease
in plasma FFA in P2Y1-deficient mice may be related to
the higher plasma levels of insulin, which is a well-known
antilipolytic and lipogenic hormone. This is supported by
and could account for the increase in body weight in P2Y1-
deficient mice as compared to wt animals. Whether
P2Y1j/j mice could have an enhanced utilization or
storage of fatty acids remains to be investigated.
In conclusion, our data in the fed and post-prandial state
in mice demonstrate a role of the P2Y1 receptor in the
maintenance of glucose homeostasis, at least in part
through negative regulation of insulin secretion. This
receptor may thus function as an autocrine loop for the
feedback control of insulin secretion through release of
ADP stored in insulin granules, thereby allowing the b cells
to rapidly adapt their response to variations in plasma
glucose. Nevertheless, we cannot exclude the possibility
that the P2Y1 receptor also acts through other metabolic
pathways.
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